Ticker
AKBACompany Name
AKEBIA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -2.38M | $ -0.01 | 1 | 262.57M |
3/31/2025 | $ -34.69M | $ -0.15 | 1 | 235.5M |
12/31/2024 | $ -40.69M | $ -0.19 | 1 | 210.95M |
9/30/2024 | $ -38.53M | $ -0.18 | 1 | 210.35M |
6/30/2024 | $ -39M | $ -0.19 | 1 | 209.71M |
3/31/2024 | $ -25.28M | $ -0.12 | 1 | 204.96M |
12/31/2023 | $ -23.38M | $ -0.12 | 1 | 187.47M |
9/30/2023 | $ -75.75M | $ -0.4 | 1 | 188.31M |
6/30/2023 | $ -34.78M | $ -0.19 | 1 | 186.82M |
3/31/2023 | $ -69.07M | $ -0.37 | 1 | 184.77M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / (Shares WA * Share Factor)
(=) FCFPS
FCFPS for AKEBIA THERAPEUTICS INC is calculated as follows: FCF [ $ -171.96M ] / (Shares WA [ 143.31M ] * Share Factor [ 1 ])
(=) FCFPS [ $ -1.2 ]
Minimum
Dec 31, 2021
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.76K |
---|---|
min | $ -7.96 |
max | $ 8.88 |
average | $ 0.8 |
median | $ 0.3 |
std | $ 2.82 |